SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  For example, here is how to disable FireFox ad content blocking while on Silicon Investor.
Biotech / Medical : Immunomedics (IMMU) - moderated
IMMU 18.53+2.9%3:59 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: sukit who wrote (49668)1/23/2019 2:22:18 PM
From: czboy  Read Replies (1) of 53345
 
Considering the magnitude of "breakthrough "designation , FDA wouldn't simply issue a CRL without ongoing or further communication if the issues can be readily corrected. The CRL is a total rejection of their manufacturing scheme: "chemistry " , "data integrity " could be very serious .
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext